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Tong-Term Management of Tetralogy of Fallot (TF)
rticles related to long-term management of the status of
lder children and young adults after repair of TF include
ssues related to assessment of pulmonary regurgitation and
iming pulmonary valve replacement as well as indications
or and results of implantation of defibrillators.
Gengsakul et al. (1) report a matched cohort study of 82
atients with pulmonary valve replacement (PVR) after TF
epair without a history of ventricular arrhythmia who were
ompared with non-PVR control subjects. Oxygen con-
umption at peak exercise did not change in either group.
or PVR subjects, there was a significant reduction in
ulmonary valve regurgitation (PR), tricuspid valve regur-
itation (TR), and right ventricular (RV) size and dysfunc-
ion on echocardiography. Symptoms and functional class
mproved after PVR, but a change in arrhythmia was not
etected. There were no sudden deaths in the PVR subjects,
hereas 4 patients died suddenly in the non-PVR group.
Meijboom et al. (2) report on 67 patients who were
ollowed from 15  3 years until 27  3 years after TF
urgery. Twenty-two patients had mild-to-moderate PR,
nd no significant changes occurred during follow-up. Of
5 patients with severe PR and severe RV dilation, 28 (62%)
emained free of symptoms and did not undergo PVR. No
dditional changes in RV size or exercise capacity were
ound. Seventeen patients had symptoms and underwent
VR; 9 of 17 improved clinically and echocardiographically,
nd QRS duration shortened. Refraining from PVR in
symptomatic patients led to no measurable deterioration in
5 of 28 patients. Referring symptomatic patients for PVR
ed to improvement in 9 of 17 patients. This article
ighlights the dilemma in following asymptomatic patients
ith significant PR. Although most showed no measurable
eterioration, in 24% there were questionable or unsatisfac-
ory results for this type of management.
Henkens et al. (3) analyzed the influence of pre-operative
R severity and RV size and function on outcome in 27
dults who had cardiac magnetic resonance imaging (MRI)
efore and after PVR. PR was not related to RV dimensions
r function before PVR, and severity of PR did not
rom the Division of Pediatric Cardiology, Vanderbilt Children’s Hospital, Nashville,u
ennessee.
Manuscript received July 5, 2008, accepted August 4, 2008.nfluence changes in RV dimensions after PVR. These data
uggest that the timing of PVR should be based on indexed
V end-systolic volume and corrected RV ejection fraction
EF) rather than severity of PR. It is unclear how PR cannot
e related to RV dimensions in this article. Nevertheless,
he preceding 3 reports emphasize that diligence is needed
n follow-up of these patients andMRI, plus exercise studies
an help in providing optimal timing for PVR before
eterioration of RV function occurs. This can be a difficult
nterprise despite all of our efforts. If we had a perfect valve
t would be much easier, but such is not the case.
Khairy et al. (4) report on implantable cardioverter-
efibrillators (ICDs) in TF patients. A total of 121 patients
ere enrolled and followed for a median of 3.7 years. The
CDs were implanted for primary prevention in 68 patients
nd for secondary prevention in 53, defined by clinical sus-
ained ventricular tachycardia (VT) or resuscitated sudden
eath. Overall, 31% received at least 1 appropriate and effective
CD discharge; actuarial rates of appropriate shocks were 7.7%
nd 10% for primary and secondary prevention, respectively. A
igher left ventricular (LV) end-diastolic pressure and nonsus-
ained VT independently predicted appropriate ICD shocks in
rimary prevention. Inappropriate shocks occurred in 6% of
atients yearly. Additionally, 36% experienced complica-
ions, of which 5% were acute, 21% were late lead-related,
nd 6% were late generator-related. Nine patients died: an
nnual mortality of 2% that did not differ between primary
nd secondary groups. Patients with TF and ICDs for
rimary and secondary prevention experience high rates of
ppropriate and effective shocks; however, inappropriate
hocks and lead-related complications are common. ICDs
emain the last resort before transplantation in attempting
o prevent sudden death in patients with severe cardiovas-
ular disease who are at risk. Complications remain a factor
n using this modality, and experienced physicians must
eigh carefully the good and the bad of this modality in TF
atients before using it. The ICD use in selected TF might
rove beneficial for primary prevention, but guidelines for
se in this situation are still unclear.
Hoohenkerk et al. (5) report 28 years of experience with
ransatrial-transpulmonary repair of 20 patients with atrio-
entricular septal defect with TF. Five patients had prior
hunts. All repairs were accomplished without a conduit.
he 2-patch technique was used to correct the atrioventric-
lar septal defect. There was no in-hospital mortality and 1
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October 28, 2008:1492–9 Year in Congenital Heart Diseaseate, noncardiac death. Six patients required 8 reoperations:
for atrioventricular (AV) valve insufficiency, 1 for residual
entricular septal defect (VSD), and 1 for pulmonary artery
ranch obstruction. Follow-up showed all 19 patients in good
linical condition without medication. Echocardiography re-
ealed good RV function, low RV outflow tract gradient, and
race PR.
These results of transatrial-transpulmonary repair of AV
eptal defect with TF are outstanding and, hopefully, can be
uplicated by others. It will be of interest to assess post-
epair patients with exercise studies and MRI.
ontan Surgery
ngoing important studies continue to seem related to
ost-Fontan natural history, methods of Fontan repair, flow
ynamics, and evaluation before and after Fontan repair.
Khairy et al. (6) report on 261 adults who had Fontan
urgery at a median age of 8 years. Perioperative mortality
radually decreased with time with 93% freedom from death
r transplantation at age 10 years, 83% at 20 years, and 70%
t 25 years. Thromboembolic death risk increased 15 years
fter surgery as predicted by clinically identified thrombus
nd lack of aspirin or warfarin therapy. Independent risk
actors for heart failure mortality were single RV morphol-
gy, higher post-operative right atrial pressure, and protein-
osing enteropathy (PLE). Incidence of sudden death was
.15%/year with most events presumed arrhythmic. Hope-
ully, patients operated at a younger age having a lateral
unnel or extracardiac connection will have less evidence of
ardiac dysfunction and do better in the long-haul. Never-
heless, this is not a rosy picture for all of those patients with
ypoplastic left hearts and systemic RVs who have had or
ill have Fontan surgery.
d’Udekem et al. (7) report on 305 consecutive patients
ho underwent a Fontan procedure with 10 hospital deaths
3%) and no death after 1990. Independent risk factors for
ortality were elevated pulmonary artery pressure and
ommon AV valve. Twenty-year survival was 84%. Recent
echniques improved late survival. The 15-year survival after
triopulmonary connection was 81% versus 94% for lateral
unnel patients. Nine patients required heart transplanta-
ion. Freedom from Fontan failure was 70% at 20 years.
fter extra-cardiac conduits were used, death, supraventric-
lar tachycardia, or failure was not noted. Although the
ontan procedure remains palliative, patient selection and
mproved techniques have minimized hospital mortality.
here is increasing rationale for converting an atrial pulmo-
ary connection to an extracardiac connection early in
atients with increasing symptomatology. The patients in
his report with lateral tunnel or extracardiac connection
perated at an earlier age had less arrhythmia, less operative
ortality, and are likely to have failure of their Fontan
irculation delayed considerably and hopefully in many cases
revented. pNakano et al. (8) report on 292 patients who underwent
xtracardiac conduit total cavopulmonary connection at an
verage age of 5.8 years, with 126 patients followed for more
han 5 years. There was 1 operative death and 6 late deaths.
ctuarial survival rate was 95% and 94% at 5 and 10 years,
espectively. Seven patients had late complications, includ-
ng new onset atrial arrhythmias in 3 patients, PLE in 2,
hromboembolism in 1, and bleeding complication in 1
atient. Seven patients underwent reoperation not related to
he conduit. Freedom from Fontan-related events was 89%
t 5 years and 85% at 10 years. Late cardiac catheterization
howed low central venous pressure of 10 mm Hg, cardiac
ndex normal at 3.6, and arterial oxygen saturation of 95%.
o patients showed conduit stenosis. Exercise performed on
01 patients showed endurance times of 76% of normal,
eak heart rate 92% of normal, and peak oxygen consump-
ion 90% of normal. There was a low incidence of systemic
entricular dysfunction with EF mildly reduced in 16%,
oderately reduced in 2%, and severely reduced in only 1
atient by echocardiographic evaluation. These authors used
arfarin plus aspirin in all patients and feel that this might
ontribute to their excellent outcomes.
Calvaruso et al. (9) report 4-year follow-up of 246
atients from 3 institutions, with restrictive but not critical
ntegrade pulmonary blood flow who received a bidirec-
ional cavopulmonary shunt with continued additional for-
ard pulmonary blood flow; 208 or 85% underwent bidi-
ectional cavopulmonary anastomosis as primary palliation,
nd 38 patients with previous pulmonary artery banding or
ther palliation were also enrolled. None had a systemic-
o-pulmonary shunt. No in-hospital deaths occurred. Dur-
ng the observational period, 30% of patients who were
onsidered optimal candidates underwent Fontan comple-
ion for increased cyanosis and/or hematocrit and/or fatigue
ith exertion. Three patients expired after total cavopulmo-
ary connection, a 4% mortality rate. The remaining 173
atients are alive with initial palliation, and all patients are
ell-palliated with an arterial oxygen saturation at rest of
0%. These authors suggest that patients who have good but
ot excessive forward pulmonary blood flow with good-
ized pulmonary arteries and low pulmonary pressure are
xcellent candidates for bidirectional Glenn without com-
letion of the Fontan operation unless they develop increas-
ng cyanosis and/or fatigue with exertion. These patients
bviously would be good candidates for completion of the
ontan, but it is hard to argue with their results of palliation
ith only the bidirectional Glenn when there is antegrade
ow that results in good-sized pulmonary arteries.
Hsia et al. (10) present data on subdiaphragmatic venous
ow dynamics in patients with Fontan circulation after dia-
hragm plication. Patients with biventricular circulation were
ompared with Fontan patients with normal diaphragms and
ontan patients who had required plication of the diaphragm
fter phrenic nerve damage. In Fontan patients with a plicated
iaphragm, inspiration-derived hepatic venous flow was sup-
ressed, and portal venous flow lost its normal expiratory
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Year in Congenital Heart Disease October 28, 2008:1492–9ugmentation. These flow dynamics are similar to those
bserved with failing Fontan circulations. Suboptimal splanch-
ic circulation might contribute to early problems of prolonged
leural effusions and ascities and potentially promote late
ontan failure. These authors document the problems with
ung flow dynamics in Fontan patients who depend on excel-
ent lung compliance for augmentation of flow into the lungs
ith inspiration. Although up to 20% to 30% of patients might
how some return of diaphragm function after plication, these
atients did not show such return and are at increased risk for
omplications when this unfortunate consequence occurs.
Ikai et al. (11) report on extracardiac conduit Fontan
peration in 36 patients 10 kg and compared them with
atients weighing more than 10 kg with similar hemody-
amic status and operative procedures. Post-operative
ourses were identical in both groups except that smaller
atients received slightly longer ventilator support, longer
leural drainage, and 8 days versus 7 days in intensive care.
he debate has continued as to whether one should use the
xtracardiac Fontan in younger patients in whom it is
xpected that the conduit will have to be replaced as they
utgrow it. The question about putting a larger conduit in
he smaller patients has come up and whether significant
ead space will be present in these patients and therefore
redispose them to arrhythmia and thrombosis. These
uthors have not shown outgrowth of the conduit at this
arly follow-up, but whether they will be better off long-
erm than patients with a total cavopulmonary pulmonary
onnection is unclear.
Brown et al. (12) evaluated pre-operative MRI versus
outine cardiac catheterization before bidirectional Glenn in
nfants with functional single ventricles with 41 patients on
ach arm of this randomized study. There were 4 treatment
rossovers: 3 to catheterization and 1 to MRI. Patients who
ere known to need catheter intervention before the pro-
edure were not included, and all patients had anesthesia for
he MRI study. Catheterization resulted in more minor
dverse events, longer pre-operative hospital stays (median,
days vs. 1 day) and higher hospital charges ($34,000 vs.
15,000). One major adverse event in the MRI suite was a
hrombosis that resulted in transfer immediately to the
atheter group, and the patient was able to be resuscitated
nd treated effectively. At 3 months’ follow-up there were
o differences in the clinical status, oxygen saturation, or
requency of reinterventions. Thus, in selected patients
RI is a safe, effective, and less costly alternative to routine
atheterization in the evaluation of young patients in whom
atheter intervention is not needed before bidirectional
lenn.
Ryerson et al. (13) report on the usefulness of heparin in
atients with single ventricle palliation and PLE. The use of
ubcutaneous heparin was first reported by this group as a
ossible means of stabilizing and improving patients with
LE. Heparin might stabilize the cell-matrix interactions at
he capillary endothelium or at the intestinal mucosa to
ecrease leakage of protein into the extravascular spaces. Ahese authors report 17 patients whose PLE appeared at an
verage of 43 months after surgery; subjective symptomatic
mprovement occurred in 76%, and 3 patients (18%) went
nto clinical remission. Compared with the period before
eparin, there was no difference in the number of hospital
dmissions or albumin infusions during the first year of
herapy. Of the 3 patients, 2 with remission remained in
ong-term remission without further therapy and have been
emoved from heparin therapy. Obviously, some patients
espond to this therapy and receive excellent long-term
alliation. It does not work for everyone, and PLE remains
ifficult to treat effectively.
Friedrich-Rust et al. (14) report on noninvasive assess-
ent of liver fibrosis in 39 patients with Fontan circulation.
hese authors used transient elastography, which is a system
sing a vibrating ultrasonic transducer, and detailed labora-
ory testing. Signs of liver fibrosis were found in 36 of 39
hildren according to the elastography method and in 28 of
9 children according to biochemical fibrosis markers.
ontan patients are at increased risk of developing liver
brosis and cirrhosis, a finding that seems identical to
ndings in patients with right heart failure of prolonged
uration. The risk increases with the age of the patient and
he time interval since the Fontan procedure. These
atients need careful attention to liver size, blood chem-
stry markers, and possibly this ultrasound method, which
ight detect problems at an early stage. Patients at higher
isk include those with more elevated venous pressure and
n enlarged liver.
Giardini et al. (15) report on the natural history of
xercise capacity after the Fontan operation in 53 patients
ith 3 tests for each patient, with an average age of 14
ears at the first test and an average of 7.7 years between
ests. Age at operation was a mean of 6 years in 22
atients with total cavopulmonary connection and 7 years
n 31 patients with atriopulmonary or atrioventricular
onnection. Exercise capacity was expressed as peak
xygen uptake that decreased at a rate of 2.6  2.7%
er year. The RV morphology and nontotal cavopulmo-
ary connection Fontan were the only predictors of a
ore rapid rate of decrease in exercise performance. This
ecline in exercise capacity in Fontan patients, particu-
arly those with systemic RVs, is worrisome. Hopefully,
ith improved flow dynamic status and earlier operation,
his can be lessened with time.
ypoplastic Left Heart Syndrome (HLHS)
pproaches to risk stratification in infants with hypoplastic
eft heart and outcomes continue to be of importance.
Glatz et al. (16) report a retrospective review of patients
ith HLHS and pre-natal restrictive atrial septal defect
ASD). Sixteen of 38 patients had the most severe form of
bstruction with only 38% survival. Pre-natal diagnosis did
ot improve survival. Eight patients had progression of
SD obstruction from the first fetal to the first post-natal
s
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October 28, 2008:1492–9 Year in Congenital Heart Diseasetudy; 7 patients underwent planned cesarean section fol-
owed by immediate surgical or catheter-based intervention
ith only 2 survivors (28%). These data document the
ritical nature of this subset of patients with HLHS. These
uthors also document the progression from a wide-open
SD at 34 weeks to virtually complete obstruction at term.
hus, these patients need careful follow-up, and fetal
ntervention needs to be further investigated; this might
ecome the best therapy for this highly lethal condition in
ts most severe form.
Ashcraft et al. (17) report on aortic arch recoarctation after
he Norwood procedure with a 30% incidence in 117 patients.
he majority of arch interventions, whether surgical or
atheter-based, occurred in the first 6 months after initial
urgery. Use of bovine pericardium showed the greatest risk for
ecoarctation. Recoarctation after the Norwood procedure
eems to still be with us, despite attempts to resect all ductal-
nd coarctation-producing tissue adequately and have the
atch pass through the proximal and distal areas of narrowing.
he increased after-load that recoarctation presents to a
ompromised RV remains a hazard for long-term outcome.
opefully, further modification of this surgical procedure
ill improve this aspect of therapy.
Hickey et al. (18) report on 362 neonates with critical LV
utflow tract obstruction enrolled by 26 institutions in the
ongenital Heart Surgeons’ Society database. Initial proce-
ure indicated intended univentricular repair (n  223; 84
eaths) or biventricular repair (n  139; 39 deaths). Incre-
ental risk factors for death after univentricular repair were
ricuspid regurgitation, smaller mitral annulus Z scores,
maller indexed dominant ventricular length, and presence
f a large ASD; risk factors after biventricular repair were
inimal LV outflow tract diameter, endocardial fibroelas-
osis, LV dysfunction, and smaller mid-aortic arch. Univen-
ricular survival advantage values, especially in borderline
andidates, were more frequent and more consequential.
se of the univentricular survival advantage tool developed
n this study might help identify infants in whom univen-
ricular repair might be a better choice than attempted
iventricular repair. It is always tempting to proceed with
iventricular repair when it seems potentially feasible in
erms of, hopefully, a better long-term outcome. These
uthors help identify patients in whom this could be a poor
trategy. The more liberal use of a Ross-Konno procedure
ith or without arch repair as well as resection of endocar-
ial fibroelastosis might improve survival for biventricular
epair patients and, hopefully, can be sorted out with a
ulti-institutional study for those who have the ability to
eal with these complex surgical options.
ransposition of the Great Arteries
ollow-up and natural history of patients undergoing arte-
ial switch procedure are of considerable importance, as
etailed in the following articles. mBové et al. (19) studied 93 children after an arterial switch
peration using echocardiography for functional and mor-
hological assessment of both reconstructed arteries. With a
ean follow-up of 5 years, aortic regurgitation (AR) of 2 or
reater developed in 10% with intact ventricular septum
ersus 23% with VSD. A VSD and major pulmonary to
ortic annulus size discrepancy were main precursors of early
eoaortic valve dysfunction, whereas development of AR of
or greater was additionally related to duration of follow-
p. After arterial switch operation, the neoaortic root is
sually enlarged but with a growth pattern comparable to
hat of a normal population. The association of a VSD and
ajor aortic root size discrepancy predisposes to both
eoaortic valve dysfunction and root enlargement. Neopul-
onary stenosis is a frequent finding but rarely has clinical
onsequences. These data indicate the need for continued
iligence in follow-up of arterial switch patients, with
articular attention to aortic root size and aortic valve
ysfunction.
Agnoletti et al. (20) studied dilation and AR late after the
rterial switch operation in 46 patients (ages 5 to 6 years) and
n 20 matched healthy control subjects. There was acute
ngulation of the aortic arch, and the ratio of the ascending
orta to descending aorta diameters was significantly greater in
atients who underwent the arterial switch operation com-
ared with control subjects. The aortic arch angle was associ-
ted with a higher degree of AR. This gothic type of angula-
ion of the aortic arch after arterial switch operation is a natural
onsequence of the French connection (posterior translocation
f the ascending aorta) and is associated with aortic
ilation and AR. Hopefully, this will not result in a
ultitude of patients with severe AR or who are predis-
osed to such in the future. Perhaps our surgical colleagues
ill figure out a way to do this operation with minimal acute
ortic angulation.
Gottlieb et al. (21) reviewed the overall mortality and
eoperation rate for 65 of 74 survivors with arterial switch
peration for dextro transposition of the great arteries,
SD, and aortic arch obstruction. Distal transverse aortic
rch z-score 2.5, tricuspid valve (TV) z-score 0,
epaired muscular VSD, and circulatory arrest time were
redictors of mortality. Small transverse arch and small TV
ere risk factors for mortality in univariate analysis and
emained significant in the subset of patients with short
irculatory arrest times, suggesting that, even when control-
ing for technical factors, anatomic risk factors predict
ortality. This is a high-risk group that includes patients
ho might be marginal candidates for 2-ventricle repair and
ight therefore need consideration for other types of
alliative or reparative operation.
Quinn et al. (22) report a retrospective study of all
atients undergoing the double-switch procedure for con-
enitally corrected transposition of the great arteries. Pa-
ients were divided into 2 groups: those not requiring
orphological LV training (n  33) and those completing
orphologic LV training by pulmonary artery banding
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Year in Congenital Heart Disease October 28, 2008:1492–9PAB) (n 11). The early results of these 2 groups were not
ifferent, but there was an increased risk of deterioration of
orphological LV function over time in patients with LV
raining. This is a worrisome result in this group of patients
ho have undergone this complex procedure with good
verall outcomes. The overall mortality was 12% for those
ot requiring training and 9% of those requiring morpho-
ogic LV training. This is obviously not different, however;
here was a 46% development of moderate to severe LV
ysfunction in patients requiring retraining versus 21% for
hose not requiring training. This group deserves careful
tudy and follow-up to try to determine the risk factors
esulting in severe dysfunction of the LV in these patients
nd attempts to prevent it in the future.
Ou et al. (23) report on computed tomography (CT)
angiography) in 133 consecutive children after arterial
witch operation. The CT was fully evaluable in 126 of 130
atients and detected all 12 patients (9.2%) in whom
nvasive coronary angiography had identified coronary le-
ions (see Figs. 1, 3, and 5 in Ou et al. [23]). These children
equire anesthesia and are given propranolol to slow their
eart rate to give optimal visualization of coronary anatomy.
This article and the succeeding editorial indicate the
xcellent quality data that can be obtained. There is a cost in
erms of radiation that was slightly higher than with
ngiography. The question of predisposition of a child to
alignancy later in life as a consequence of radiation
xposure is suggested by 1 follow-up of children undergoing
ardiac catheterization indicating a doubling of suspected
ardiac malignancies over a mean follow-up of 29 years (24)
lthough MRI can result in similar images in many patients
ithout any radiation risk, it is pointed out that relatively
ow spatial resolution, long scan time, and potential need for
nesthesia are drawbacks when compared with CT imaging.
opefully, these issues can be addressed in the future for
RI studies and/or CT can be done with lower radiation.
he need for assessing coronary anatomy so exquisitely in
rterial switch patients could be argued, but these patients
eed to enter adult life with a roadmap of their coronary
natomy to simplify later evaluation for acquired heart
isease and to be certain significant lesions are dealt with in
timely and optimal fashion.
ardiac Surgery
his section details several important studies related to
eneral cardiac surgery and outcomes, including some with
arge databases.
Curzon et al. (25) report on cardiac surgery mortality in
,022 infants ages 0 to 90 days weighing 1 to 2.5 kg and
,505 patients 2.5 to 4 kg who underwent surgery from
002 through 2004 at 32 participating centers within the
ociety of Thoracic Surgeons Congenital Heart Surgery
atabase. The smaller infants had an increased mortality for
otal anomalous pulmonary venous connection, coarctation,
rterial switch, systemic to pulmonary artery shunt for tulmonary atresia with VSD, and the Norwood procedure.
t is always difficult to decide whether to proceed with
urgery in the small infant or hope for more growth and
ore maturity. Usually with symptomatology present in
omplex lesions, these patients do not grow well and might
ecome worse candidates with time. Deciding the optimal
ime to operate is difficult. These data will give cardiologists
nd surgeons a reasonable picture to present to parents
efore deciding on the timing of surgery.
Li et al. (26) report on a prospective, randomized,
lacebo-controlled trial evaluating the pharmacodynamics
f clopidogrel in children ages 0 to 24 months with a cardiac
ondition at risk for thrombosis. Patients were randomized
o clopidogrel versus placebo in a 3:1 ratio in sequential
roups. Of the 116 patients who were enrolled, 92 were
andomized and 73 completed the study. A total of 79% of
he randomized and treated patients were taking aspirin as
ell as clopidogrel. Compared with the placebo, clopidogrel
esulted in 49% inhibition of the maximum extent of
latelet aggregation. There was marked interpatient vari-
bility in the degree of platelet aggregation inhibition within
ach treatment-dose group and age group. No serious
leeding events occurred. This study shows that clopidogrel
s well-tolerated in infants and young children at this dose
nd might be useful to decrease morbidity and mortality in
hose patients at risk for thrombotic disease.
Nieminen et al. (27) examined causes and modes of late
eath after pediatric cardiac surgery in 6,024 patients who
urvived their first operation during the years 1953 to 1989.
total of 9% or 592 died during the 45-year follow-up.
urvival improved in patients operated in succeeding de-
ades. The cause of death was confirmed by post-mortem
valuation in 81%. The majority died because of their
HD, and the main cause for CHD-related deaths was
ongestive heart failure (CHF) in 40%. Other causes in-
luded perioperative (26%), sudden (22%), and cardiovas-
ular (12%) deaths. Accidental deaths and suicides were
imilar to the general population. There were 13 coarctation
atients who died suddenly, and 5 had untreated aortic
tenosis. In 4 patients, the underlying cause was a ruptured
r dissected aorta. The overall incidence of lethal endocar-
itis was 0.07% (4 of 6,024). Two of these patients had a
icuspid aortic valve, 1 had a recoarctation, and 1 had
niventricular CHF after Fontan operation. The number of
atients lost to follow-up was only 4% of 6,024 who
urvived their first operation, and the cause of death was
onfirmed in 98%. This gives further impetus to the need
or long-term careful follow-up of adults with CHD.
Geva et al. (28) report on the risk factors for reoperation
or discrete subaortic stenosis in 111 subjects. Sixteen
atients reported reoperation, and median follow-up was 8
ears. Independent predictors of reoperation available before
rst surgery were 6 mm between the aortic valve and the
bstruction and peak gradient by Doppler 60 mm Hg. If
ntraoperative variables were also considered, involvement of
he mitral or aortic valve leaflets requiring surgical peeling
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October 28, 2008:1492–9 Year in Congenital Heart Diseaselso predicted recurrent stenosis. One of the more difficult
ssues for a cardiologist and surgeon is the recurrence of
iscrete subaortic stenosis in patients who seem to have an
xcellent result at early follow-up. These findings hopefully
ill result in fewer patients coming to reoperation as well as
mproved pre-operative counseling about recurrence risk.
Brown et al. (29) report on outcomes of 604 operations
or 539 patients with Ebstein’s anomaly. The mean age at
he time of operation was 24 years with a range of 8 days to
9 years. One hundred eighty-two patients had TV repair,
nd 337 had tricuspid valve replacement (TVR). The
0-day mortality was 5.9% for the entire cohort (2.7% after
001). Late survival was 85% at 10 years and 71% at 20
ears. A multivariate analysis of overall mortality for the
atient’s first operation showed that increased hematocrit,
ulmonary valve stenosis, TVR, absence of ablation of an
ccessory pathway, miscellaneous arrhythmia procedure,
ranch pulmonary enlargement, need for mechanical sup-
ort post-operatively, emergency chest opening in the in-
ensive care unit, and absence of sinus rhythm at dismissal
ere all predictive of mortality. When only pre-operative
haracteristics were included, increased hematocrit values,
itral valve regurgitation requiring surgical intervention,
rior cardiac procedure, and moderate-to-severe to severe
eduction in RV systolic function were associated with
ortality. Eighty three percent of patients rated their health
s excellent or good. There is a vast amount of data in this
arge series of patients with Ebstein’s anomaly. These
uthors prefer TVR in patients in whom the possibility of a
ood-to-excellent repair of the TV is unlikely, and a
ioprosthesis is the usual choice because of excellent dura-
ility in adults plus the ability to treat atrial arrhythmias
ith a concomitant maze procedure. Timing of the opera-
ion is very important. These authors use abnormal exercise
olerance, cyanosis, the presence or progression of arrhyth-
ias, and progressive increase in RV size as indicators for
peration. If echocardiography suggests a high probability
f TV repair, earlier operation is advised. The RV function
s felt to always be abnormal in Ebstein’s anomaly, but
uantification of RV function is challenging. Cardiac MRI
an be useful for this purpose. This remains a difficult lesion
o decide on operation timing in patients with minimal
ymptoms, minimal/moderate RV dilation, and mildly ab-
ormal function. Earlier rather than later surgery is desir-
ble before poor RV function becomes easily detectable.
Corno et al. (30) report on comparison of conventional
AB with the use of an implantable telemetrically con-
rolled FloWatch (Endoart, Lausanne, Switzerland) device.
here were 20 patients in each group with similar age and
eight before PAB. Indications were preparation for biven-
ricular repair in 16 of 20, univentricular repair in 2 of 20,
nd LV training of in 2 of 20 with conventional PAB versus
3 of 20, 5 of 20, and 2 of 20 infants, respectively, with the
loWatch PAB. There were 3 early and 2 late deaths after
onventional PAB group and 2 late deaths with the Flo-
atch group. Post-operative mechanical ventilation and intensive care unit and hospital stays were significantly
onger after conventional PAB. Reoperation to adjust the
AB was required in 7 of 20 infants after conventional
AB, whereas no reoperations were required after Flo-
atch PAB. Average cost in the intensive care unit and
ospital was significantly less with the FloWatch group
nd resulted in overall lower cost, despite the $10,000 cost
f the device.
This device has been proven useful by this group, and
opefully it can be more widely applied. You can not only
ncrease the degree of banding but also decrease it with the
loWatch device. In addition, there is no distortion of the
ulmonary artery and no need for pulmonary arterioplasty
fter removal.
nterventional Catheterization
ardiac interventions continue to generate important
bservations.
Silversides et al. (31) studied the predictors of atrial
rrhythmias after device closure of secundum ASD in 200
dults. Twenty percent of patients had a history of atrial
achycardia (AT). Early follow-up was available for 90% of
he patients. The prevalence of AT was 17%. Of 171
atients with later follow-up (mean time 1.9 years), data
ere available for 90%, and AT was detected in 16%.
losure resulted in alleviation of symptoms, but symptoms
lone did not identify patients at risk of recurrent AT. After
SD closure, the likelihood of remaining arrhythmia-free
as highest in patients without a history of AT and those
ge 40 years at closure.
This provides good data for counseling patients regarding
ercutaneous ASD closure. Unfortunately, the data indicate
hat arrhythmias might still be an issue after closure with a
imilar prevalence as has been reported after surgical closure.
he message is clear: early closure of ASDs that are large
nough to cause right heart enlargement is highly desirable.
Butera et al. (32) report on safety and efficacy of trans-
atheter closure of perimembranous VSD in 104 patients
ith a mean age of 14 years (range 0.6 to 63 years). The
evice was implanted successfully in 96% and median device
ize was 8 mm. No deaths occurred. Total occlusion rate
as 47% at completion, 84% at discharge, and 99% during
ollow-up. A total of 13 early complications occurred, but in
ll but 2 subjects these were transient. The median
ollow-up was 38 months, and the most significant compli-
ation was atrioventricular block (AVB), which required
acemaker implantation in 6 subjects (5.7%; 2 in the early
hase and 4 during the follow-up). All patients experiencing
VB were6 years of age. These authors show good results
or closure of perimembranous VSD. Unfortunately, AVB
ccurred in a greater percentage than found in surgical
eries. In addition, they closed 1 VSD as small as 3 mm in
iameter. Such small defects should not be closed by
nterventional or surgical means, in my opinion. The long-
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ared with a 6% prevalence of AVB.
Sievert et al. (33) report on 30 patients who were enrolled
or patent foramen ovale closure without an implant by the
uccessful application of radiofrequency energy. Success was
chieved in 27 patients. The remaining 3 patients received
n implantable closure device. There were no serious
rocedure-related adverse events, including recurrent
trokes, deaths, or perforations that occurred as a result of
he procedure. The mean follow-up was 6 months, and 13
f the 30 patients experienced patent foramen ovale (PFO)
losure after the first procedure. Nine of the patients whose
FO remained patent after the first procedure elected to
eceive a second radiofrequency procedure. The PFO was
losed for 6 of those patients after the second procedure,
hich resulted in a secondary closure rate of 63%. This
tudy demonstrates that transcatheter closure of an intra-
ardiac defect without a permanent implant is technically
easible. Whether patients are at risk of thrombosis remains
o be seen. It is an exciting potential application of small
SD closure without the use of an implant.
edical Therapy
haddy et al. (34) report on the randomized trial of
arvedilol in children with CHF. One hundred and sixty-
ne children and adolescents were enrolled with CHF due
o dilated cardiomyopathy or CHD (inclusive of both
ystemic LVs and systemic RVs). Patients were randomized
n a 1:1:1 ratio to twice-daily dosing with placebo, low-dose
arvedilol, or high-dose carvedilol. Primary outcome was a
omposite measure of CHF outcomes, which was described
s “worsened,” “improved,” or “unchanged.” There was no
tatistically significant difference in the composite end point
f the patients assigned to placebo and that of either dosage
roup. Carvedilol was not associated with changes in CHF
t 8 months compared with placebo. Most therapies used in
hildren have been evaluated only in trials of adults, and it
s assumed that results will be applicable to children as well;
his trial demonstrates that supposition is not always true.
his was a difficult trial to pull off in terms of getting
nough patients to perform randomization with different
ubgroups. The authors should be congratulated for their
ork. Hopefully, further data can be obtained with
imilar trials in terms of medical treatment of CHF in
atients with CHD.
Doughan et al. (35) report a retrospective analysis of
edical therapy for patients with systemic RV dysfunction
ith transposition of the great arteries. A significant im-
rovement in New York Heart Association functional class
as found after 4 months of therapy with beta-blocker
rugs (carvedilol or metroprolol). Functional improvement
as significant mostly in those patients with pacemakers
ho received higher maintenance doses of carvedilol. The
V end-diastolic area was significantly greater in untreated
atients at the end of the follow-up period, whereas it was
3nchanged in treated patients. This retrospective study
uggests that a larger controlled trial of the use of beta-
locker drugs in older patients with systemic RVs might be
seful, despite the prior report in children (34).
enetics
runeau (36) reviews recent studies that have uncovered the
enetic basis for some of the common forms of CHD and
rovides insight into how the heart develops and how
ysregulation of heart development can lead to abnormali-
ies. This article indicates how far we’ve come and yet how
uch there is still to understand about what factors regulate
he development of the heart as well as its function later in
ife. Hopefully, articles like these will stimulate young
cientists to get involved in this blossoming field.
Hinton et al. (37) report on 38 probands with HLHS in
hich a 3-generation family history was obtained and a
equential sampling strategy with echocardiograms on fam-
ly members was performed. A total of 235 participants were
ecruited. Hertability of HLHS and associated cardiovascu-
ar malformation (CVM) were estimated with maximum-
ikelihood–based variance decomposition. All HLHS pro-
ands had aortic valve hypoplasia and dysplasia; dysplasia of
he mitral, tricuspid, and pulmonary valves were also noted.
verall, 21 of 38 (55%) families had more than 1 affected
ndividual, and 36% of participants had CVMs, including
1% with bicuspid aortic valve. The heritability of HLHS
lone and with associated CVM were 99% and 74%,
espectively. The sibling recurrence risk for HLHS was 8%
nd for CVM was 22%. These data add further insight into
he heritability of left-sided lesions and further impetus to
esearch into the aortic causes of these defects.
ulmonary Atresia
ardiner et al. (38) report on morphological and functional
redictors of eventual circulation in the fetus with pulmo-
ary atresia (PAIVS) or critical pulmonary stenosis (CPS)
ith intact septum. These authors studied 21 fetuses with
AIVS (18 fetuses) or CPS (3 fetuses) between 1998 and
004. The best predictive scores for specific gestations were
ulmonary valve z-score, median TV z-score, and the
ombination of median pulmonary valve and the median
V/mitral valve ratio. The best predictive scores for post-
atal outcomes in PAIVS/CPS are a combination of mor-
hologic and physiological variables, which predict a biven-
ricular circulation with a sensitivity of 92% and specificity
f 100% before 26 weeks. These data should prove quite
seful for patient selection for possible fetal intervention to
reserve biventricular outcome.
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